2Jellis C,Martin J,Narula J. Assessment of nonischemic myocardial fibrosis[J].Journal of the American College of Cardiology,2010.89-97.
3Herpel E,Pritsch M,Koch A. Interstitial fibrosis in the heart:differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated,ischaemic and valvular cardiomyopathy[J].Histopathology,2006.736-747.
4Mann DL,Bristow MR. Mechanisms and models in heart failure:the biome-chanical model and beyond[J].Circulation,2005.2837-2849.
5de Leeuw N,Ruiter DJ,Balk AH. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy[J].Transplant International,2001.299-306.
6Karamitsos TD,Francis JM,Myerson S. The role of cardiovascular magnetic resonance imaging in heart failure[J].Journal of the American College of Cardiology,2009.1407-1424.
7To ACY,Desai M. Role of cardiac magnetic resonance imaging in assessing ischemic and nonischemic cardiomyopathies[J].Expert Review of Cardiovascular Therapy,2012,(02):223-233.
8White JA,Yee R,Yuan X. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony[J].Journal of the American College of Cardiology,2006,(10):1953-1960.doi:10.1016/j.jacc.2006.07.046.
9Pastor A,Voigt T,Schaeffter T. Usefulness of cardiac magnetic resonance in early assessment of cardiomyopathies:myocardial fibrosis is a common denominator[J].Curr Cardiovasc Imaging Rep,2012.77-82.
10Papavassiliu T,Schnabel P,Schroder M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis[J].European Heart Journal,2005.2395.
